Ocugen (OCGN) Enterprise Value Growth (3y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 33.71% |
| Jun 30, 2024 | 48.61% |
| Mar 31, 2024 | 16.16% |
| Dec 31, 2023 | -17.97% |
| Sep 30, 2023 | -40.93% |
| Jun 30, 2023 | -67.69% |
| Mar 31, 2023 | -188.56% |
| Dec 31, 2022 | -130.31% |
| Sep 30, 2022 | -87.96% |
| Jun 30, 2022 | -453.42% |
| Mar 31, 2022 | -649.10% |
| Dec 31, 2021 | -287.81% |
| Sep 30, 2021 | -250.94% |
| Jun 30, 2021 | -136.23% |
| Mar 31, 2021 | -42.42% |
| Dec 31, 2020 | -44.42% |
| Sep 30, 2020 | -14.83% |
| Jun 30, 2020 | 6.89% |
| Mar 31, 2020 | 49.21% |
| Dec 31, 2019 | 38.44% |
| Sep 30, 2019 | 26.15% |
| Jun 30, 2019 | 65.07% |
| Mar 31, 2019 | 76.20% |
| Dec 31, 2018 | 62.52% |
| Sep 30, 2018 | 59.62% |
| Jun 30, 2018 | 42.11% |
| Mar 31, 2018 | 33.69% |
| Dec 31, 2017 | 48.53% |
| Sep 30, 2017 | -57.05% |
| Jun 30, 2017 | -33.59% |
| Mar 31, 2017 | -93.58% |